Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Bendamustine Hydrochloride for Injection

Approval Number

国药准字H20253886

Company深圳万乐药业有限公司

Registration Date

April 15, 2025

Drug Information

Generic Name

注射用盐酸苯达莫司汀

Dosage Form

注射剂

Strength

100mg（按C₁₆H₂₁Cl₂N₃O₂•HCl计）

Drug Type

化学药品

Registration Date

April 15, 2025

Company Information

Applicant Company

Company Name深圳万乐药业有限公司

Company Address

深圳市坪山新区兰竹东路国家生物医药产业基地万乐药业大厦

Manufacturing Company

Company Name深圳万乐药业有限公司

Company Address

深圳国家生物医药产业基地坪山新区兰竹东路万乐药业大厦

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用盐酸苯达莫司汀 - NMPA 批准文号 | MedPath